The research waspresentedthis weekend at the American Association for the Advancement of Sciences annual conference.
Side-effects were similar between the two groups, though those on liraglutide did experience more gastrointestinal symptoms.
The findings are based on a very small sample size, so should be viewed with added caution.
The obesity medication Saxenda, made with liraglutide. Newer GLP-1 drugs like semaglutide have proven to be even more effective at helping people lose weight.Image: Mohammed_Al_Ali (Shutterstock)
But they line up with other recent reports suggesting that GLP-1 medications can help treat substance use disorders.
And thats led to speculation that these drugs could reduce peoples other unhealthy cravings.
Right now, the evidence supporting this potential benefit is little more than anecdotal.
But there are already randomized, controlled clinical trials underway testing semaglutide for alcohol dependence.
I feel very hopeful; there may be a new treatment for opioid use disorder.
News from the future, delivered to your present.